drugset / Trial / NCT02395692

Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma

NCT02395692

Phase 2 Terminated 20 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial studies how well methoxyamine works when added to standard temozolomide in treating patients with glioblastoma that has come back. Drugs used in chemotherapy, such as methoxyamine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Timeline

Start
2015-12-18
Primary completion
2017-02-16
Completion
2017-02-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Methoxyamine Small molecule Oral
Subject Temozolomide Small molecule Oral

Indications